Concepedia

Author

Tobias Kanacher

Bayer (Germany)ORCID

Also Known As

Tobias Kanacher

7

Publications

201

Citations

4

H-Index

11

Concepts

All Affiliations

Bayer (Germany)
TK

About

Tobias Kanacher is an author at Bayer (Germany) specializing in pharmacokinetics, pharmacokinetic modeling, and pharmacodynamic modeling.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

2

2

153

2

Pharmacology

2

2

153

3

Pharmacodynamic Modeling

2

2

153

4

Health Sciences

1

1

111

5

Drug Resistance

1

1

111

Tobias Kanacher

×

4

Publications

200

Citations

4

H-Index

YearCitations

A Systematic Evaluation of the Use of Physiologically Based Pharmacokinetic Modeling for Cross-Species Extrapolation

Christoph Thiel, Sebastian Schneckener, Ahmed Ghallab,

Journal of Pharmaceutical Sciences

2014

111

Clarithromycin, Midazolam, and Digoxin: Application of PBPK Modeling to Gain New Insights into Drug–Drug Interactions and Co-medication Regimens

Daniel Moj, Nina Hanke, Hannah Britz,

The AAPS Journal

2016

42

A Physiologically-Based Pharmacokinetic (PBPK) Model Network for the Prediction of CYP1A2 and CYP2C19 Drug–Drug–Gene Interactions with Fluvoxamine, Omeprazole, S-mephenytoin, Moclobemide, Tizanidine, Mexiletine, Ethinylestradiol, and Caffeine

Tobias Kanacher, Andreas Lindauer, Enrica Mezzalana,

Pharmaceutics

2020

25

CYP3A4‐mediated effects of rifampicin on the pharmacokinetics of vilaprisan and its UGT1A1‐mediated effects on bilirubin glucuronidation in humans

Niladri Chattopadhyay, Tobias Kanacher, Manuela Casjens,

British Journal of Clinical Pharmacology

2018

22

Page 1